Addition of Omalizumab Improved Functional Health Status in Patients With Impaired Quality of Life Associated With Moderate-Severe Persistent Allergic Asthma

Rationale A significant number of patients with moderate-severe asthma are not well controlled and consequently have impaired quality of life (QoL) despite treatment with inhaled corticosteroids (ICS) and other therapies.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S154-S154
Main Authors: Massanari, M, Sacco, P, Kianifard, F, Maykut, R, Zeldin, R
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Confidence intervals
Drug therapy
Quality of life
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale A significant number of patients with moderate-severe asthma are not well controlled and consequently have impaired quality of life (QoL) despite treatment with inhaled corticosteroids (ICS) and other therapies.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.565